485 related articles for article (PubMed ID: 23771538)
1. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
[TBL] [Abstract][Full Text] [Related]
2. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
3. PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.
Jendrzejewski J; Thomas A; Liyanarachchi S; Eiterman A; Tomsic J; He H; Radomska HS; Li W; Nagy R; Sworczak K; de la Chapelle A
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1370-7. PubMed ID: 26274343
[TBL] [Abstract][Full Text] [Related]
4. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
5. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737
[TBL] [Abstract][Full Text] [Related]
6. Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells.
Xu YB; Du QH; Zhang MY; Yun P; He CY
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2486-94. PubMed ID: 24089228
[TBL] [Abstract][Full Text] [Related]
7. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
[TBL] [Abstract][Full Text] [Related]
8. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.
Saleem M; Kweon MH; Johnson JJ; Adhami VM; Elcheva I; Khan N; Bin Hafeez B; Bhat KM; Sarfaraz S; Reagan-Shaw S; Spiegelman VS; Setaluri V; Mukhtar H
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14825-30. PubMed ID: 16990429
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
[TBL] [Abstract][Full Text] [Related]
10. S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling.
Liu H; Wang L; Wang X; Cao Z; Yang Q; Zhang K
World J Surg Oncol; 2013 Apr; 11():93. PubMed ID: 23618129
[TBL] [Abstract][Full Text] [Related]
11. Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model.
Shi Y; Zou M; Collison K; Baitei EY; Al-Makhalafi Z; Farid NR; Al-Mohanna FA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2373-9. PubMed ID: 16551737
[TBL] [Abstract][Full Text] [Related]
12. Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells.
Ma X; Yang Y; Wang Y; An G; Lv G
Cancer Lett; 2010 Dec; 299(2):171-81. PubMed ID: 20855150
[TBL] [Abstract][Full Text] [Related]
13. RLN2 regulates in vitro invasion and viability of osteosarcoma MG-63 cells via S100A4/MMP-9 signal.
Ren XF; Zhao H; Gong XC; Wang LN; Ma JF
Eur Rev Med Pharmacol Sci; 2015; 19(6):1030-6. PubMed ID: 25855929
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo.
Zhang K; Yu M; Hao F; Dong A; Chen D
Cancer Biomark; 2016 Sep; 17(3):281-291. PubMed ID: 27802204
[TBL] [Abstract][Full Text] [Related]
15. PRAME promotes in vitro leukemia cells death by regulating S100A4/p53 signaling.
Xu Y; Rong LJ; Meng SL; Hou FL; Zhang JH; Pan G
Eur Rev Med Pharmacol Sci; 2016; 20(6):1057-63. PubMed ID: 27049257
[TBL] [Abstract][Full Text] [Related]
16. Blocking TGF-β inhibits breast cancer cell invasiveness via ERK/S100A4 signal.
Wang XG; Meng Q; Qi FM; Yang QF
Eur Rev Med Pharmacol Sci; 2014; 18(24):3844-53. PubMed ID: 25555875
[TBL] [Abstract][Full Text] [Related]
17. S100A4 promotes squamous cell laryngeal cancer Hep-2 cell invasion via NF-kB/MMP-9 signal.
Zhang W; Liu Y; Wang CW
Eur Rev Med Pharmacol Sci; 2014; 18(9):1361-7. PubMed ID: 24867514
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Zhang G; Li M; Jin J; Bai Y; Yang C
Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
[TBL] [Abstract][Full Text] [Related]
19. Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC.
Chi BJ; Du CL; Fu YF; Zhang YN; Wang RW
Int J Clin Exp Pathol; 2015; 8(10):12533-40. PubMed ID: 26722441
[TBL] [Abstract][Full Text] [Related]
20. S100A4 siRNA inhibits human pancreatic cancer cell invasion in vitro.
Li N; Song MM; Chen XH; Liu LH; Li FS
Biomed Environ Sci; 2012 Aug; 25(4):465-70. PubMed ID: 23026527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
